http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
ROSEN, HIGHLY REGARDED INVESTOR COUNSEL, Encourages Solaris Energy Infrastructure, Inc. Investors to Secure Counsel Before Important May 27 Deadline in Securities Class Action - SEI
-
ROSEN, A LEADING LAW FIRM, Encourages Viatris Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - VTRS
-
PPTA DEADLINE NOTICE: ROSEN, A LEADING LAW FIRM, Encourages Perpetua Resources Corp. Investors with Losses in Excess of $100K to Secure Counsel Before Important May 20 Deadline in Securities Class Act
-
TBBK DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages The Bancorp, Inc. Investors to Secure Counsel Before Important May 16 Deadline in Securities Class Action - TBBK
-
ROSEN, A LEADING LAW FIRM, Encourages XP Inc. Investors to Inquire About Securities Class Action Investigation - XP
-
ROSEN, A LEADING LAW FIRM, Encourages Ibotta, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - IBTA
-
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Civitas Resources, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CIVI
-
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Canopy Growth Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - CGC
-
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Bitfarms Ltd. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BITF
-
ROSEN, LEADING TRIAL ATTORNEYS, Encourages BigBear.ai Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BBAI
-
Merck (MRK) announces FDA approval of WELIREG
-
ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Cerevel Therapeutics Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - CERE
-
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Bakkt Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BKKT
-
Armlogi Holding Corp. Announces Fiscal 2025 Third Quarter and Nine-Month Results
-
FDA Approves Merck’s WELIREG® (belzutifan) for the Treatment of Adults and Pediatric Patients 12 Years and Older With Locally Advanced, Unresectable, or Metastatic Pheochromocytoma or Paraganglioma
-
Former Mafia Capo Dominick Cicale Launches Official Crypto Nostra: A Utility-Focused Digital Asset Venture
-
Precipio Announces its Q1-2025 Financial Results
-
AZ Blue in Action Invests $200,000 to Support Students Across Northern Arizona
-
Long-Serving Director Alan J. Murray Retiring; Eugenio Garza y Garza and Iain J. Mackay Elected to O-I Board of Directors
-
Long-Serving Director Alan J. Murray Retiring; Eugenio Garza y Garza and Iain J. Mackay Elected to O-I Board of Directors
-
Rekor Systems Reports First Quarter 2025 Financial Results
-
ZimVie to Participate in the Stifel 2025 Jaws & Paws Conference
-
Korro to Participate in Upcoming Investor Conferences
-
Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences
-
Zentalis Pharmaceuticals Reports First Quarter 2025 Financial Results and Operational Progress
-
Illumina To Webcast Upcoming Investor Conference
-
ZimVie to Participate in the Stifel 2025 Jaws & Paws Conference
-
Omnicell (OMCL) Announces New Products for Perioperative and Clinic Settings
-
Omnicell Announces New Products for Perioperative and Clinic Settings
-
Eledon Pharmaceuticals Reports First Quarter 2025 Operating and Financial Results
-
Personalis to Participate at the Craig-Hallum 22nd Annual Investor Conference
-
Celcuity Inc. Reports First Quarter 2025 Financial Results and Provides Corporate Update
-
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
Usio Announces First Quarter 2025 Financial Results
-
MDxHealth Reports Q1-2025 Results
-
Boralex (BLX) announces voting results for Board election
-
ROSEN, A GLOBALLY RECOGNIZED LAW FIRM, Encourages Backblaze, Inc. Investors to Inquire About Securities Class Action Investigation - BLZE
-
Boralex announces the election of its directors and highlights of its Annual Meeting of Shareholders
-
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Teleflex Incorporated Investors to Inquire About Securities Class Action Investigation - TFX
-
Meet the 2025 We Love Tech Awards Winners: Where Innovation Takes Center Stage
-
TOP RANKED ROSEN LAW FIRM Encourages Actinium Pharmaceuticals, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ATNM
-
SVVC DEADLINE: ROSEN, NATIONAL TRIAL ATTORNEYS, Encourages Firsthand Technology Value Fund, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important May 20 Deadline in Securiti
-
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Open Lending Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - LPRO
-
SANA DEADLINE: ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Sana Biotechnology, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important May 20 Deadline in Securities Class A
-
SOL NEWS: Kaanch presale live at Solana’s Presale Price — with XRP-Like Utility Already Live
-
GRANDE LAKES ORLANDO LAUNCHES EXCLUSIVE PACKAGE FOR TICKETHOLDERS OF NEW UNIVERSAL EPIC UNIVERSE THEME PARK
-
AbbVie (ABBV) Announces FDA Approval of EMRELIS for Adults With Previously Treated Advanced Non-Small Cell Lung Cancer With High c-Met Protein Overexpression
-
U.S. FDA Approves EMRELIS™ (telisotuzumab vedotin-tllv) for Adults With Previously Treated Advanced Non-Small Cell Lung Cancer (NSCLC) With High c-Met Protein Overexpression
-
TEKLYNX Achieves Expanded Validation Across a Broad Range of Zebra Printers
-
Bird Canada Brings E-Scooters and E-Bikes to Halifax
